Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field

Triple negative breast cancers (TNBCs) represent 10%–20% of primary breast cancers, and despite having greater initial sensitivity to cytotoxic chemotherapy, patients with TNBCs have higher rates of distant metastasis and a poorer prognosis compared with patients with hormone receptor positive and/o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Yam, Clinton, Mani, Sendurai A., Moulder, Stacy L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2017
Konular:
Breast Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599192/
https://ncbi.nlm.nih.gov/pubmed/28559413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0095
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller